MAPK14 and atrial fibrillation: In experimental models, the pharmacologic inhibition or genetic ablation of TNF (Tnf) or MAPK14 significantly attenuated AF onset and atrial remodeling following strenuous exercise, establishing a mechanistic link between TNF-α signaling and stress-induced arrhythmogenic remodeling [93].